GOOD NEWS ON THE VACCINE FRONT FOR DEVELOPING COUNTRIES, ELIZABETH TRACEY REPORTS
Efforts to supply vaccines to prevent serious illness and death for children in developing countries have just gotten a serious boost from vaccine manufacturers, many of which have pledged favorable pricing structures to ensure an affordable supply. Orin Levine, a vaccine expert at Johns Hopkins and one member of an international panel on this issue, is elated.
LEVINE: I believe that the biggest reason that the companies felt comfortable at this time to do that is because we have proven that with long term, predictable commitments of financing from groups like the Gates foundation, governments like the UK and US, and growing national investments by poorer countries themselves that the market for vaccines in developing countries is now less risky and more predictable, and when they eliminate that risk, it allows the manufacturers the confidence to bring the prices down. :35
Levine says we all benefit from more widespread vaccination. At Johns Hopkins, Iím Elizabeth Tracey.